Photosensitizers and antioxidants: a way to new drugs?

Area of Science:

• Biochemistry
• Photochemistry
• Oncology

Background:

• Photodynamic therapy (PDT) utilizes photosensitizers and oxygen to generate reactive species for treating diseases with uncontrolled cell proliferation.
• Antioxidants typically scavenge reactive species, often reducing PDT efficacy.
• However, specific antioxidants can unexpectedly enhance PDT's photodamaging effects.

Purpose of the Study:

• To investigate the dual role of antioxidants in photodynamic therapy.
• To explore strategies for enhancing PDT efficacy through antioxidant modulation.
• To evaluate the potential of novel antioxidant-modified photosensitizers for therapeutic applications.

Main Methods:

• Administration of specific antioxidants (ascorbic acid, alpha-tocopherol, butyl-4-hydroxyanisole) at adequate concentrations to cells undergoing PDT.
• Investigation of the influence of transition metals and timing of antioxidant administration on PDT outcomes.
• Design, synthesis, and testing of antioxidant carrier sensitizers for antibacterial PDT.

Main Results:

• Certain antioxidants, at specific concentrations, were found to enhance the photodamaging activity of PDT.
• Transition metals and the timing of antioxidant administration were identified as critical factors influencing PDT efficacy.
• Antioxidant carrier sensitizers demonstrated promising results in antibacterial PDT applications.

Conclusions:

• The interaction between antioxidants and PDT is complex, with some antioxidants capable of enhancing therapeutic outcomes.
• Optimizing the use of antioxidants, transition metals, and administration timing can improve PDT effectiveness.
• Integrating antioxidant moieties into photosensitizer molecules presents a promising avenue for developing novel and highly effective PDT drugs.